Lookup NU author(s): Eleanor Mitchell,
Dr James Frith,
Professor Julia Newton
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2019 British Society for Haematology and John Wiley & Sons LtdImmune thrombocytopenic purpura (ITP) is an autoimmune disorder characterised by low platelet counts and increased bleeding risk. In 2009, two cross-sectional studies determined that fatigue and cognitive impairment (CI) were common in ITP. Here, we report the results from a longitudinal study of 34 people with ITP. Fatigue severity remained unchanged over 7 years, and CI significantly improved. Future fatigue and CI severity could be predicted using baseline severity scores. These findings may be reassuring for ITP patients, as symptoms remain stable over time. Furthermore, using baseline scores to predict future severity could aid the clinical management of ITP.
Author(s): Mitchell E, Frith J, Newton J
Publication type: Article
Publication status: Published
Journal: British Journal of Haematology
Pages: Epub ahead of print
Online publication date: 23/05/2019
Acceptance date: 11/04/2019
ISSN (print): 0007-1048
ISSN (electronic): 1365-2141
PubMed id: 31119732
Altmetrics provided by Altmetric